Targeting Antitumor Immune Response for Enhancing the Efficacy of Photodynamic Therapy of Cancer: Recent Advances and Future Perspectives.
Yamin YangYue HuHongjun WangPublished in: Oxidative medicine and cellular longevity (2016)
Photodynamic therapy (PDT) is a minimally invasive therapeutic strategy for cancer treatment, which can destroy local tumor cells and induce systemic antitumor immune response, whereas, focusing on improving direct cytotoxicity to tumor cells treated by PDT, there is growing interest in developing approaches to further explore the immune stimulatory properties of PDT. In this review we summarize the current knowledge of the innate and adaptive immune responses induced by PDT against tumors, providing evidence showing PDT facilitated-antitumor immunity. Various immunotherapeutic approaches on different cells are reviewed for their effectiveness in improving the treatment efficiency in concert with PDT. Future perspectives are discussed for further enhancing PDT efficiency via intracellular targetable drug delivery as well as optimized experimental model development associated with the study of antitumor immune response.
Keyphrases
- photodynamic therapy
- immune response
- fluorescence imaging
- drug delivery
- dendritic cells
- minimally invasive
- healthcare
- systematic review
- induced apoptosis
- squamous cell carcinoma
- cancer therapy
- papillary thyroid
- oxidative stress
- cell death
- squamous cell
- newly diagnosed
- combination therapy
- replacement therapy
- childhood cancer